Cargando…
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
We developed a novel intranasal SARS-CoV-2 subunit vaccine called NARUVAX-C19/Nano based on the spike protein receptor-binding domain (RBD) entrapped in mannose-conjugated chitosan nanoparticles (NP). A toll-like receptor 9 agonist, CpG55.2, was also added as an adjuvant to see if this would potenti...
Autores principales: | Tabynov, Kairat, Solomadin, Maxim, Turebekov, Nurkeldi, Babayeva, Meruert, Fomin, Gleb, Yadagiri, Ganesh, Renu, Sankar, Yerubayev, Toktassyn, Petrovsky, Nikolai, Renukaradhya, Gourapura J., Tabynov, Kaissar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372096/ https://www.ncbi.nlm.nih.gov/pubmed/37495639 http://dx.doi.org/10.1038/s41598-023-39402-0 |
Ejemplares similares
-
Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023) -
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
por: Tabynov, Kairat, et al.
Publicado: (2022) -
A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
por: Babayeva, Meruert, et al.
Publicado: (2022) -
A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
por: Tabynov, Kairat, et al.
Publicado: (2022) -
Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model
por: Tabynov, Kairat, et al.
Publicado: (2022)